- Research article
- Open Access
- Open Peer Review
Factors associated with Group A Streptococcus emm type diversification in a large urban setting in Brazil: a cross-sectional study
© Tartof et al; licensee BioMed Central Ltd. 2010
- Received: 24 March 2010
- Accepted: 11 November 2010
- Published: 11 November 2010
Group A Streptococcus (GAS) strain diversity varies across different regions of the world, according to low versus high-income countries. These differences may be related to geographic, environmental, socioeconomic, or host-related factors. However, local factors may also affect strain diversity. We compared the emm types of GAS isolates from children with and without sore throat in one large urban setting in Brazil.
Children 3-15 years of age were consecutively recruited from slum and non-slum pediatric outpatient clinics between April-October, 2008. Throat cultures were performed and data intake forms were completed. GAS isolates were typed by emm sequencing.
From 2194 children, 254 (12%) GAS isolates were obtained. Of 238 GAS isolates that were emm-typed, 61 unique emm types were identified. Simpson's diversity index of the emm types was higher among isolates from slum children [97% (96%-98%)] than those of non-slum children [92% (89%-96%)]. Two emm types (66.0, 12.0) were more frequently isolated from children with sore throat (p < 0.05), and one emm type (27G.0) demonstrated a protective effect.
The emm type diversity from children attending slum clinics resembled the emm diversity of low income countries rather than that of children attending a non-slum clinic in the same city. Local factors, such as crowding, may enhance the frequency of GAS transmission and horizontal gene transfers that contribute to increased strain diversity in the slums. GAS vaccine coverage and control of GAS infections will need to take these local factors and strain differences into consideration.
- Sore Throat
- Necrotizing Fasciitis
- Vaccine Coverage
- Slum Community
- Slum Population
Group A Streptococcus (Streptococcus pyogenes; GAS) causes a wide spectrum of diseases, including pharyngitis and pyoderma to more severe diseases such as toxic shock syndrome, necrotizing fasciitis, glomerulonephritis and rheumatic heart disease (RHD) . Children are the major reservoir of GAS . The highest prevalence of GAS infections and their complications are found in developing countries .
GAS strain typing is frequently used to characterize the epidemiology and pathogenesis of GAS infections. The most common target of typing methods is the M protein, which is a cell surface virulence factor serving as a target of the immune response to GAS that confers type-specific resistance. A sequence-based typing system called emm sequence typing, based on the N-terminus hypervariable region (5') of the M protein gene, is now widely used . Many studies have been conducted using emm typing to show associations of specific strain types with disease outcomes [5–9]. Information about geographic emm type distribution can also be used to assess candidate vaccine coverage [10, 11], including that of a 26-valent vaccine that has recently completed phase II trials .
Epidemiologic studies have revealed that developing countries have high emm type diversity [13, 14], while high-income countries are more likely to have a limited number of emm types [15–18]. This pattern was clearly demonstrated in a recent systematic review of 120 articles and reports on GAS emm types . It found a higher diversity of emm types in Africa and the Pacific compared to high-income countries, which may be related to differences in geographic, environmental, socioeconomic or host factors. However, comparisons which are made across continents cannot evaluate the impact of local factors on genotype distribution. In this study, we compared the emm types of GAS isolates obtained from children in slum and wealthy neighborhoods in the same city, Salvador, Brazil to examine the influence of urban environmental, demographic, and socioeconomic factors on diversification of GAS. Furthermore, we collected isolates from children with and without sore throat to identify associations of certain emm types with clinical outcome.
This study was conducted at three pediatric outpatient emergency clinics (clinics A, B, and C). Clinical services at Clinic A and Clinic B are offered free to patients through the publicly funded Unified Health System (SUS). These clinics serve primarily low-income patients. The socioeconomic status and demographic characteristics (household density, income, education level of mother and father) of patients seeking care at Clinic A and Clinic B are similar. Clinic C serves wealthier clientele and only those with private insurance. Clinic B is located 24 km from Clinic C, Clinic A is located 32 km from Clinic B, and Clinic A is located 11 km to Clinic C. The size of the patient population is comparable between the three clinics. Each clinic receives about 5000-6000 children as outpatients each year.
Patients aged 3-15 years were consecutively recruited from Clinics A-C from April 17, 2008 to October 31, 2008. Recruitment occurred while patients waited for their medical evaluation, or immediately following their appointment. Parents/guardians of children were approached by a research team member for recruitment and consent to participate in the study. At this time, a brief description of the study, risks, benefits, and issues of confidentiality were provided. Following consent from parents/guardians and verbal assent from minors, a trained member of the research team administered a standardized questionnaire and collected a throat swab sample of the study participant. All members of the research team were trained in standardized technique for both procedures. Institutional Review Board (IRB) approval was obtained from all hospitals, the Comissão Nacional de Ética em Pesquisa (Conep) (National Bioethics Commission of Brazil), the Comitê de Ética em Pesquisa-Centro de Pesquisa Gonçalo Moniz - Fiocruz (Ethics Committee for Research - Fiocruz), and the University of California, Berkeley Committee for the Protection of Human Subjects.
Slum communities were defined according to the United Nations Human Settlements Program as human settlement areas that have one or more of the following characteristics: 1) inadequate access to safe water; 2) inadequate access to sanitation and other infrastructure; 3) poor structural quality of housing; 4) overcrowding; and 5) insecure residential status . In the neighborhoods served by Clinic A and B, these characteristics vary at the individual household level. However, what these slum settlements all have in common is that they were illegally built on land with unclear tenure status. The structural quality of housing also varies among residential units in these slums (red brick houses with unfinished wall and tile roof; shacks made of discarded lumber and corrugated tin roof), but the common characteristics are that they were all built with no official permit.
Cases were defined as those children whose chief complaint was sore throat. GAS culture-positive sore throat was defined as a child with a sore throat in whom GAS was isolated from the throat swab. Controls were defined as those visiting the clinics for other reasons. Exclusion criteria included use of antibiotics in the past two weeks, or any illness requiring inpatient hospitalization on the day of recruitment. Slum children were defined as those attending Clinics A and B, and non-slum children were those attending Clinic C.
The following variables were recorded: reason for visit to the hospital, date of birth of patient, sex of patient, household income, home address, whether in school and where, whether in daycare and where, total number of people living in house, number of children 15 years or younger in household, whether had sore throat in past six months, level of education of mother, level of education of father, and co-morbidities.
Laboratory Sample Isolation and Identification
Swab cultures were obtained from the pharynx of the study children following a standard protocol. All study technicians were observed periodically at the clinic sites for proper and consistent swabbing technique. A sterile cotton swab tip was applied to the posterior pharynx and tonsils, as recommended by the Infectious Disease Society of America (IDSA) . The swabs were immediately placed in Stuart transport medium, transported to the laboratory and plated the same day of collection on 5% sheep blood agar. The plates were incubated at 37°C for 24 - 48 h with 5% CO2. Streptococci were phenotypically identified by beta-hemolysis, colony morphology, and the catalase test. Carbohydrate group identification (Groups A, B, C, F, G) was performed by positive latex agglutination (Remel PathoDx Strep Grouping Latex Test Kit, Remel, Lenexa, KS, USA). Pure culture samples were stored in 5% glycerol at -80°C until further use.
emm-typing of all isolates were performed as described by the Center for Disease Control and Prevention (CDC) protocol http://www.cdc.gov/ncidod/biotech/strep/protocol_emm-type.htm.
Analyses were conducted by STATA 11.0 (Stata Inc., College Station, Texas). Categorical variables were compared with the chi-square test. Student's t-test and ANOVA were used to compare means, and multivariable logistic regression was used to evaluate the association between specific emm types and case status while controlling for covariates. Models were restricted to those children with culture-positive GAS. Simpson's index of diversity was used to calculate the variation of the number of emm types of GAS isolates by clinic or by case status . Higher index measures represent greater diversity of emm types, since the method calculates the probability that any two randomly selected isolates from the same population will be of different emm types. Confidence intervals (CI's, 95%) for the diversity index measures were calculated as previously described .
Demographic and clinical characteristics
Between April 17, 2008 and October 31, 2008, 2194 children aged 3-15 years (759 in Clinic A, 518 in Clinic B, 917 in Clinic C), who met the eligibility criteria, were identified from the three study clinics. Of 2181 children with data on case status, 624 (28.6%) came with a complaint of sore throat (cases), and 1557 (71.4%) came for other illnesses. The distribution of reasons for visit among the controls was comparable across the three hospitals (data not shown).
Demographic characteristics and streptococcal group distributions of children attending slum and non-slum clinics
Total Population (n = 2194)
Non-sluma(n = 917)
Slumb(n = 1277)
Mean Age in years (95%CI)
Mean # people/house (95%CI)
Mean # people ≤ 15 yrs./house (95%CI)
The difference in mean age between cases (7.4 years) and controls (7.5 years) or between patients who tested positive for GAS (7.6 years) or negative for GAS (7.5) were not significant, both in the total study population, and when stratified by slum status.
Demographic and streptococcal group distributions, by sore throat and carriage in slum versus non-slum children
Non-slum (n = 915) a
Slum (n = 1266) b
Mean Age (95% CI)
N = 274
N = 594
N = 312
N = 882
Mean # persons per household (95% CI)
Mean # < 15 yrs. per household (95% CI)
Diversity of emm types in non-slum versus slum populations
Simpson's Diversity Index
Number of Unique emmTypes
Number of Isolates
Simpson's diversity index for all the emm types was 96% (94%-97%). The index was 92% (89%-96%) for the non-slum GAS emm types, and 97% (96%-98%) for slum emm types. The CI's for slum vs. non-slum only overlap at the lower bound estimate for slum, and the upper bound estimate of non-slum. Separating the two slum communities, the Simpson's diversity index was 96% (94%-98%) for Clinic A, and 97% (96%-99%) for Clinic B. For both slum and non-slum populations, the diversity index was lower for cases than for controls [non-slum: 90% vs. 93%; slum 96% vs. 98%] (Table 3).
Only 7 emm types 12.0 (n = 38), 1.0 (n = 23), st2904.1 (n = 13), 66.0 (n = 12), 87.0 (n = 9), 49.3 (n = 8), and 27G.0 (n = 8) comprised 46.6% of the total. There were 22 emm types that were represented by only a single isolate. In total, 25 distinct emm types were detected only in slum children, compared with only 8 emm types which were found only in non-slum children. emm types which were represented by only one isolate were more likely to be found in children 10 years or older, than in those 9 and younger, which approached statistical significance (p = 0.08).
emm type and case status
Common emm types and association with sore throat or carriage, among GAS culture-positive (n = 253) patients
Case (n = 128)
Control (n = 125)
In this study, 100 (42.0%) of the 238 emm typed isolates, and 15 (24.6%) of the 61 emm types would be covered by the 26-valent M-protein-based GAS vaccine, assuming cross-immunity between type 1.2 and subtype 1.25, between type 101 and subtype 101.1, and between type 33.0 and subtype 33.1 . Stratifying by populations, 45 (47.9%) of 94 isolates and 10 (27.8%) of 36 emm types from non-slum children would be covered by the vaccine. In the slum, the coverage for isolates would be 52 (36.1%) of 144 isolates, and 11 (20.8%) of 53 emm types.
In children presenting with sore throat, 55 (44.7%) of 123 emm typed isolates, and 13 (30.2%) of 43 emm types would be covered by the current 26-valent M-protein-based GAS vaccine. In the non-slum population, 25 (51.0%) of 49 emm typed isolates, and 8 (33.3%) of 24 emm types would be covered. In the slum population, 32 (43.2%) of 74 emm typed isolates, and 10 (29.4%) of 34 emm types would be covered by the vaccine.
In Salvador, Brazil we found significant differences in emm type diversity among GAS isolates obtained from different populations in the same city. The diversity index was significantly higher among GAS isolates from children residing in slum communities (97%) compared to those living in wealthier neighborhoods (92%). In fact, the diversity index of the non-slum GAS isolates was closer to that of emm types reported from high income countries (92%) than to those found in the slum populations of the same city Salvador . This study suggests that GAS strain diversification may be influenced by local factors. Such factors may include crowding which is more prevalent in slum communities. Crowding may facilitate increased transmission opportunities and possible horizontal gene transfers that contribute to strain diversification. For socioeconomic reasons, slum residents are also less likely to undergo antibiotic treatment for sore throat. Our data found significant differences in household density, type of health insurance plan, and income between slum versus non-slum communities (Table 1).
In addition to emm type differences in GAS strains across high-income vs. low-income populations in the same city, we found certain emm types to be over or under-represented among children with sore throat [emm66.0 (OR = 8.7), emm12.0 (OR = 2.2), emm27G.0 (OR = 0.1)]. Furthermore, we were able to identify clinically relevant strains that comprised less than 5% (emm66.0) and less than 3% (emm27G.0) of the sample population. Further laboratory studies are warranted to determine why certain emm types predominate in clinical cases (emm66.0, emm12.0) or are inversely associated with sore throat (emm27G.0).
A vaccine against GAS will have substantial benefits worldwide. However, the impact on disease reduction could vary by region depending on the vaccine composition. Currently, the only vaccine to complete phase I/II trials is a 26-valent recombinant M protein vaccine [12, 24]. In our study, only 42% of the total isolates, and 44.7% of isolates from cases, would be covered by the 26-valent M-protein-based GAS vaccine. Furthermore, the coverage of the 26-valent vaccine in all slum (36%) versus non-slum (48%) isolates would not be equal even within the same city.
This study suggests that local demographic and socioeconomic factors may contribute to the diversification of GAS emm types, and that distinct bacterial population distribution occurs between different neighborhoods separated by 11-32 km in the same city. This distinction might be particularly pronounced in cities with slums. We note that it is not simply poverty itself that determines this difference [25, 26]. As the world expands toward the projected population size of two billion slum residents in less than 30 years, it will be essential to better elucidate the slum structural dynamics which contribute to major differences in disease outcomes and vaccine coverage .
Centers for Disease Control and Prevention Grants for Public Health Research Dissertation (R36).
The authors declare that they have no competing interests.
We are grateful to the medical staff and study patients at all participating clinics. We would particularly like to acknowledge Tais Bispo and Ana Lucia Barros Reis for assisting in sample collection, and Claudia Alves, Eva Raphael, and Hillary Berman for assistance with work in the laboratory. We thank Arthur Reingold for his critical review of the study.
- Cunningham MW: Pathogenesis of group A streptococcal infections. Clin Microbiol Rev. 2000, 13 (3): 470-511. 10.1128/CMR.13.3.470-511.2000.View ArticlePubMedPubMed CentralGoogle Scholar
- Bisno AL: Streptococcus pyogenes. Principles and Practice of Infectious Diseases. Edited by: Gerald L Mandell GD, John E Bennett. 1990, New York: Churchill Livingstone, 1519-1528. ThirdGoogle Scholar
- Carapetis JR, Steer AC, Mulholland EK, Weber M: The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005, 5 (11): 685-694. 10.1016/S1473-3099(05)70267-X.View ArticlePubMedGoogle Scholar
- Beall B, Facklam R, Thompson T: Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol. 1996, 34 (4): 953-958.PubMedPubMed CentralGoogle Scholar
- Stollerman GH: The relative rheumatogenicity of strains of group A streptococci. Mod Concepts Cardiovasc Dis. 1975, 44 (7): 35-40.PubMedGoogle Scholar
- Veasy LG, Tani LY, Daly JA, Korgenski K, Miner L, Bale J, Kaplan EL, Musser JM, Hill HR: Temporal association of the appearance of mucoid strains of Streptococcus pyogenes with a continuing high incidence of rheumatic fever in Utah. Pediatrics. 2004, 113 (3 Pt 1): e168-172. 10.1542/peds.113.3.e168.View ArticlePubMedGoogle Scholar
- Miner LJ, Petheram SJ, Daly JA, Korgenski EK, Selin KS, Firth SD, Veasy LG, Hill HR, Bale JF: Molecular characterization of Streptococcus pyogenes isolates collected during periods of increased acute rheumatic fever activity in Utah. Pediatr Infect Dis J. 2004, 23 (1): 56-61. 10.1097/01.inf.0000105180.76624.33.View ArticlePubMedGoogle Scholar
- Kaplan EL, Johnson DR, Cleary PP: Group A streptococcal serotypes isolated from patients and sibling contacts during the resurgence of rheumatic fever in the United States in the mid-1980s. J Infect Dis. 1989, 159 (1): 101-103.View ArticlePubMedGoogle Scholar
- O'Loughlin RE, Roberson A, Cieslak PR, Lynfield R, Gershman K, Craig A, Albanese BA, Farley MM, Barrett NL, Spina NL, et al: The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis. 2007, 45 (7): 853-862. 10.1086/521264.View ArticlePubMedGoogle Scholar
- Dale JB: Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments. Vaccine. 1999, 17 (2): 193-200. 10.1016/S0264-410X(98)00150-9.View ArticlePubMedGoogle Scholar
- Batzloff MRPM, Olive C, Good MF: Advances in potential M-protein peptide-based vaccines for preventing rheumatic fever and rheumatic heart disease. Immunol Res. 2006, 35 (3): 233-248. 10.1385/IR:35:3:233.View ArticlePubMedGoogle Scholar
- McNeil SA, Halperin SA, Langley JM, Smith B, Warren A, Sharratt GP, Baxendale DM, Reddish MA, Hu MC, Stroop SD, et al: Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers. Clin Infect Dis. 2005, 41 (8): 1114-1122. 10.1086/444458.View ArticlePubMedGoogle Scholar
- Abdissa A, Asrat D, Kronvall G, Shittu B, Achiko D, Zeidan M, Yamuah LK, Aseffa A: High diversity of group A streptococcal emm types among healthy schoolchildren in Ethiopia. Clin Infect Dis. 2006, 42 (10): 1362-1367. 10.1086/503422.View ArticlePubMedGoogle Scholar
- Dey N, McMillan DJ, Yarwood PJ, Joshi RM, Kumar R, Good MF, Sriprakash KS, Vohra H: High diversity of group A Streptococcal emm types in an Indian community: the need to tailor multivalent vaccines. Clin Infect Dis. 2005, 40 (1): 46-51. 10.1086/426443.View ArticlePubMedGoogle Scholar
- Kim SJ, Kim EC, Cha SH, Kaplan EL: Comparison of M-serotypes of Streptococcus pyogenes isolated from healthy elementary school children in two rural areas. J Korean Med Sci. 1996, 11 (2): 133-136.View ArticlePubMedPubMed CentralGoogle Scholar
- Tanaka D, Gyobu Y, Kodama H, Isobe J, Hosorogi S, Hiramoto Y, Karasawa T, Nakamura S: emm Typing of group A streptococcus clinical isolates: identification of dominant types for throat and skin isolates. Microbiol Immunol. 2002, 46 (7): 419-423.View ArticlePubMedGoogle Scholar
- Johnson DR, Stevens DL, Kaplan EL: Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. J Infect Dis. 1992, 166 (2): 374-382.View ArticlePubMedGoogle Scholar
- Smeesters PR, Vergison A, Campos D, de Aguiar E, Deyi VY, Van Melderen L: Differences between Belgian and Brazilian Group A Streptococcus Epidemiologic Landscape. PLoS ONE. 2006, 1: e10-10.1371/journal.pone.0000010.View ArticlePubMedPubMed CentralGoogle Scholar
- Steer AC, Law I, Matatolu L, Beall BW, Carapetis JR: Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect Dis. 2009, 9 (10): 611-616. 10.1016/S1473-3099(09)70178-1.View ArticlePubMedGoogle Scholar
- Programme UNHS: The challenge of slums: global report on human settlements 2003. 2003, Nairobi: UN HABITATGoogle Scholar
- Bisno AL, Gerber MA, Gwaltney JM, Kaplan EL, Schwartz RH: Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America. Clin Infect Dis. 2002, 35 (2): 113-125. 10.1086/340949.View ArticlePubMedGoogle Scholar
- Simpson E: Measurement of diversity. Nature. 1949, 163: 688-10.1038/163688a0.View ArticleGoogle Scholar
- Grundmann H, Hori S, Tanner G: Determining confidence intervals when measuring genetic diversity and the discriminatory abilities of typing methods for microorganisms. J Clin Microbiol. 2001, 39 (11): 4190-4192. 10.1128/JCM.39.11.4190-4192.2001.View ArticlePubMedPubMed CentralGoogle Scholar
- Hu MC, Walls MA, Stroop SD, Reddish MA, Beall B, Dale JB: Immunogenicity of a 26-valent group A streptococcal vaccine. Infect Immun. 2002, 70 (4): 2171-2177. 10.1128/IAI.70.4.2171-2177.2002.View ArticlePubMedPubMed CentralGoogle Scholar
- Kyobutungi C, Ziraba AK, Ezeh A, Ye Y: The burden of disease profile of residents of Nairobi's slums: Results from a Demographic Surveillance System. Popul Health Metr. 2008, 6: 1-10.1186/1478-7954-6-1.View ArticlePubMedPubMed CentralGoogle Scholar
- Madise NJ, Banda EM, Benaya KW: Infant mortality in Zambia: socioeconomic and demographic correlates. Soc Biol. 2003, 50 (1-2): 148-166.PubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/10/327/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.